TD Cowen analyst Josh Jennings maintained a Buy rating on Humacyte (HUMA – Research Report) today and set a price target of $10.00. The ...

Humacyte Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of 0.00% with a gross margin of 86.22%. The profit margin, also known as the ...

Piper Sandler analyst Allison Bratzel maintained a Hold rating on Humacyte (HUMA – Research Report) today and set a price target of ...

Check the time stamp on this data. Updated AI-Generated Signals for Humacyte Inc. (HUMA) available here: HUMA.

On Friday, Humacyte Inc (HUMA) stock saw a modest uptick, ending the day at $5.73 which represents a slight increase of $0.18 or 3.24% from the prior close of $5.55. The stock opened at $5.49 and ...

In the latest market close, Humacyte, Inc. (HUMA) reached $5.70, with a +0.53% movement compared to the previous day. This change outpaced the S&P 500's 0.76% loss on the day. Meanwhile, the Dow lost ...

Huma Qureshi shares her enthusiasm for her upcoming police drama 'Bayaan,' set to showcase at the Busan Asian Project Market.

Humacyte (NASDAQ:HUMA – Get Free Report)‘s stock had its “buy” rating reaffirmed by Benchmark in a research note issued to ...

Huma Qureshi wraps up the shoot for Director Vipul Mehta's Gulabi, starring Parambrata Chattopadhyay, Dibyendu Bhattacharya ...

Huma Qureshi, who is all set to appear in her next film 'Gulabi' gave fans an exciting update by announcing that the movie's ...

Huma Qureshi has just completed filming for her highly anticipated movie Gulabi, a poignant drama that centers around themes ...

In the latest market close, Humacyte, Inc. (HUMA) reached $5.70, with a +0.53% movement compared to the previous day. This change outpaced the S&P 500's 0.76% loss on the day. Meanwhile ...